Status:
COMPLETED
Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections
Lead Sponsor:
Illinois Retina Associates
Collaborating Sponsors:
Alcon Research
Conditions:
Intravitreal Injection Patients
Eligibility:
All Genders
21-100 years
Phase:
PHASE4
Brief Summary
Antibiotic eye drops are being used before and after intravitreal injections. Currently there is no study indicating the benefit of there usage or their dosage. In this study we compare the efficacy ...
Eligibility Criteria
Inclusion
- Patient who need intravitreal injections patients who are willing to participate in the study
Exclusion
- Patients who are allergic to Vigamox or who have taken any eye drops within the past 3 weeks
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2011
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT00690313
Start Date
August 1 2008
End Date
April 1 2011
Last Update
August 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Illinois Retina Associates
Harvey, Illinois, United States, 60426